Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 25, 2008 11:21:32 AM CDT



Heparin Supply Chain Shaky in China

Posted Feb 28, 08 2:07 PM CST in Business World 

(Newser) – With at least four US patients dead and hundreds suffering complications from the blood-thinning drug heparin, the New York Times follows the supply chain back to Chinese slaughterhouses that deal with the pig intestines that provide raw material for the drug. Though companies say the chain is secure, the Times finds it vulnerable to contamination and lack of oversight.

American investigators are trying to determine where in the process the crude heparin, refined from pig intestines, is being contaminated. Heparin-maker Baxter International has stopped producing multi-dose vials of the drug while investigators audit the records of a US company’s Chinese subsidiary, Changzhou SPL, which collects and refines the raw material.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
Chinese workers watch a pharmaceutical production line at a Beijing factory.   (Getty Images)
A Chinese pharmaceutical worker holds vials of medicine.   (Getty Images)
« Prev« Prev | Next »Next » Slideshow
Our editors also recommend:

Threads (1 of 2)



Loading...

Loading...

Today's Most Popular


Other World Stories

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »